Revision of the Protocol Recommended for Studies of Safety from Hepatitis of Clotting Factor Concentrates
- 1 November 1989
- journal article
- international committee-communications
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 61 (03) , 532-534
- https://doi.org/10.1055/s-0038-1646630
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Reduced risk of non‐A, non‐B hepatitis after a first exposure to ‘wet heated’factor VIII concentrateBritish Journal of Haematology, 1987
- Assessment for evidence of non a-non b hepatitis in patients given n-heptane-suspended heat-treated clotting factor concentratesThrombosis Research, 1987
- Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous TransfusionsNew England Journal of Medicine, 1987
- Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated BloodAnnals of Internal Medicine, 1986
- NON-A, NON-B HEPATITIS AFTER FACTOR VIII CONCENTRATE TREATED BY HEATING AND CHLOROFORMThe Lancet, 1985
- NON-A, NON-B HEPATITIS AND HEAT-TREATED FACTOR VIII CONCENTRATESThe Lancet, 1985
- High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinBritish Journal of Haematology, 1985
- Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.BMJ, 1983
- Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre.BMJ, 1983